Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus

Clinical Biochemistry

Volumn 42, Issue 13-14, 2009, Pages 1394-1400

  Ali, Ehab M M ^a   Shehata, Hanan Hussien ^b   Ali Labib, Randa ^b   Esmail Zahra, Lamia M ^a  

^a Faculty of Science   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

Arylesterase (AE); Hepatitis C virus (HCV); Malondialdehyde (MDA); Myloperoxidase (MPO); Nitric oxide (NO); Oxidative stress; Paraxonase (PON1)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; OXIDIZING AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; OXIDANTS; PEROXIDASE; ROC CURVE; SPECTROPHOTOMETRY;

EID: 69249218964     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.06.007     Document Type: Article

References (43)

1. Trapero-Marugan M., Gonzalez-Moreno L., Chaparro-Sanchez M., Moreno-Monteagudo J.A., Borque M.J., and Moreno-Otero R. Treatment regimens for patients with chronic hepatitis C. Minerva Gastroenterol. Dietol. 54 (2008) 209-217
2. Zekri A.R., ElDin H.M., Bahnassy A.A., Khaled M.M., Omar A., Fouad I., El-Hefnewi M., et al. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4. Virol. J. 14 (2007) 4-16
3. Beard M.R., and Jones B.E. Hepatitis C virus and oxidative stress: a dangerous liaison. Future Virol. 1 (2006) 223-232
4. Olalye M.T., and Rocha J.B.T. Commonly used tropical medicine plants exhibit distinct in vitro antioxidant activities against hepatotoxins in rat liver. Exp. Toxicol. Pathol. 58 (2007) 433-438
5. Seki S., Kitada T., Yamada T., Sakaguchi H., Nakatani K., and Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J. Hepatol. 37 (2002) 56-62
6. Koruk M., Aksoy H., Akcay F., and Onuk M.D. Antioxidant capacity and nitric oxide in patients with hepatic cirrhosis. Ann. Clin. Lab. Sci. 32 (2002) 252-256
7. Hon W.M., Lee K.H., and Khoo H.E. Nitric oxide in liver diseases: friend, foe, or just passerby?. Ann. N.Y. Acad. Sci. 962 (2002) 275-295
8. Shah V., Lyford G., Gores G., and Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterol 126 (2004) 903-913
9. Reynolds W.F., Patel K., Pianko S., Blatt L.M., Nichlas J.J., and McHutchison J.G. A genotyping association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection. Genes Immunity 3 (2002) 345-349
10. Kobori L., Sarvary E., Nemes B., Lakatos M., Fehervari I., Gorog D., et al. The role of oxidative stress and arterial blood supply in the transplanted liver function. Orv. Hetil. 45 (2003) 2219-2223
11. Ferre N., Camps J., Prats E., Vilella E., Paul A., Figuera L., et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin. Chem. 48 (2002) 261-268
12. Mackness M.I., Durrington P.N., and Mackness B. The role of paraoxonase 1 activity in cardiovascular disease potential for therapeutic intervention. Am. J. Cardiovasc. Drugs 4 (2004) 211-217
13. Charlton-Menys V., Liu Y., and Durrington P.N. Semiautomated method for the determination of serum paraoxonase activity using paraoxon as substrate. Clin. Chem. 52 (2006) 453-457
14. Baskol G., Baskol M., and Kocer D. Oxidative stress and antioxidant defense in serum of patients with non-alcoholic steatohepatitis. Clin. Biochem. 40 (2007) 776-780
15. Kilic S.S., Aydin S., Kilic N., Erman F., and Celik I. Serum arylesterase and paraoxonase activity in patients with chronic hepatitis. World J. Gastroenterol. 14 (2005) 7351-7354
16. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39 (1993) 561-577
17. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-410
18. Vodovotz Y. Modified microassay for serum nitrite and nitrate. BioTechniques 20 (1996) 390-394
19. Buchmann R., Hasilik A., Van Dyke T.E., Nunn M., and Lang D.E. PMN responses in chronic periodontal disease: elevation of gingival crevicular fluid enzymes and elastase-alpha-1-proteinase inhibitor complex. J. Clin. Periodontal. 29 (2002) 563-572
20. Kao L.R., Motoyama N., and Dauterman W.C. Multiple forms of esterases in mouse, rat, and rabbit liver and their role in hydrolysis of organophosphorous and pyrethoid insecticides. Pestic. Biochem. Physilo. 23 (1985) 66-73
21. Gil F., Gonzalvo M.C., Hernandaz A.F., Villanueva E., and Pla A. Difference in the kinetic properties effect of calcium and sensitivity to inhibitor of paraoxon hydrolase activity in rat plasma and microsomal fraction from rat liver. Biochem. Pharmacol. 48 (1994) 1559-1568
22. Osman H.G., Gabr O.M., Lotfy S., and Gabr S. Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian J. Med. Microbiol. 25 (2007) 323-329
23. Loguercio C., and Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic. Biol. Med. 34 (2003) 1-10
24. Cardin R., Saccoccio G., Masutti F., Ballentani S., Farianati F., and Tiribelli C. DNA oxidative damage in leukocytes correlates with severity of HCV-related liver disease: validation in an open population study. J. Hepatol. 34 (2001) 587-592
25. Thoren F., Romero A., Lindh M., Dahlgren C., and Hellstrand K. A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J. Leuk. Biol. 76 (2004) 1180-1186
26. Waris G., Turkson J., Hassanien T., and Siddiqui A. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J. Virol. 79 (2005) 1569-1580
27. Levent G., Ali A., Ahmet A., Polat E.C., Aytac C., Ayse E., et al. Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2β plus ribavirin therapy. J. Transl. Med. 20 (2006) 25
28. Mansurova F.K., Mutikhova K.H., and Olimova S.O. (2005): Lipid peroxidation and anti-oxidative protection in patients with chronic type C hepatitis. Klin. Med. 83 (2005) 39-42
29. De Maria N., Colantoni A., Fagiuoli S., Liu G.J., Rogers B.K., Farinati F., et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic. Biol. Med. 21 (1996) 291-295
30. Boya P., Pena A., Beloqui O., Larrea E., Conchillo M., Castelruiz Y., et al. Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J. Hepatol. 31 (1999) 808-814
31. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., and Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 235 4792 (1987) 1043-1046
32. Bulmer A.C., Blanchfield J.T., Toth I., Fassett R.G., and Coombes J.S. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199 (2008) 390-396
33. Zhu W., and Fung P.C. The roles played by crucial like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl4-induced acute liver injury of mice. Free Rad. Biol. Med. 29 (2000) 870-880
34. Sass G.K., Koerber R., Bang R., Guehring H., and Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 107 (2002) 439-447
35. Kandemir O., Polat A., and Kaya A. Inducible nitric oxide synthase expression in chronic viral hepatitis and its relation with histological severity of disease. J. Viral. Hepatol. 9 (2002) 419-423
36. Nauseef W.M. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int. J. Hematol. 74 (2001) 125-133
37. Hoy A., Tregouet D., Leininger-Muller B., Poirier O., Maurice M., Sass C., et al. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur. J. Hum. Genet. 9 (2001) 780-786
38. Nakamuta M., Ohashi M., Tanabe Y., Hiroshige K., and Nawata H. High plasma concentration of myeloperoxidase in cirrhosis: a possible marker of hypersplenism. Hepatol. 18 (1993) 1377-1383
39. Brown K.E., Brunt E.M., and Heinecke J.W. Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver. Am. J. Pathol. 159 (2001) 2081-2088
40. Gangadharan B., Antrobus R., Dwek R.A., and Zitzmann N. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin. Chem. 53 (2007) 1792-1799
41. Ferre N., Marsillach J., Camps J., Mackness B., Mackness M., Riu F., et al. Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J. Hepatol. 45 (2006) 51-59
42. Bafikol M., Bafikol G., Deniz K., Ozbakir O., and Yucesoy M. A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis. Turk. J. Gastroenterol. 16 (2005) 119-123
43. Marsillach J., Ferre N., Vila M.C., Lligona A., Mackness B., Mackness M., et al. Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease. Clin. Biochem. 40 (2007) 645-650